OcuSci Inc. Secures Secures Second Utility Patent for Innovative Dry Eye Treatment
OcuSci Inc., a leader in dry eye treatments, announced the granting of a second utility patent for the MGrx Dry Eye Treatment System. Dry eye syndrome affects millions globally and is one of the leading reason for patients to visit a vision clinic. The MGrx offers a clinically proven solution to those suffering from dry eye while also reducing the cost of in-clinic treatment in comparison to existing technologies. - October 04, 2024
Press Releases 1 - 1 of 1